SC
CDNA icon

Savant Capital’s CareDx CDNA Stock Holding History

Savant Capital’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9,286
Closed -$290K – 1435
2024
Q3 		$290K Buy
+9,286
New +$231K ﹤0.01% 1106

Other funds holding CDNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Savant Capital's CDNA Position: Q4 2024 in Review

Savant Capital sold out of CareDx (CDNA) in Q4 2024, closing a stake of 9,286 shares — an estimated $290K sold.

Savant Capital first reported a position in CDNA in Q3 2024 and held it in 1 quarter. The position peaked at $290K in Q3 2024. 210 funds tracked by Wall St. Rank hold CDNA as of Q4 2024.

  • Savant Capital reported no remaining CareDx position as of Q4 2024 after selling out during the quarter.
  • Savant Capital sold 9,286 CareDx shares in Q4 2024, an estimated $290K.
  • Savant Capital first reported a position in CareDx in Q3 2024 and held it in 1 quarter.
  • Savant Capital's CareDx position peaked at $290K in Q3 2024.
  • 210 funds tracked by Wall St. Rank held CareDx as of Q4 2024.

Based on Savant Capital's 13F filing for Q4 2024, filed 29 Jan 2025.